ioSkeletal Myocytes Human iPSC-derived skeletal myocytes
Introducing highly-defined, consistent, and reliable human muscle cells for research, disease modeling, and high throughput screening across areas such as muscle, neuromuscular, and associated metabolic disorders. ioSkeletal Myocytes, part of the bit.bio ioCells portfolio, have been reprogrammed from human induced pluripotent stem cells (iPSCs) using bit.bio's precise reprogramming technology: opti-ox™
Highly-defined, consistent and reliable
Express key myofilament proteins in days
Receive your quote directly from the manufacturer.
bit.bio’s opti-ox cellular reprogramming allows for human pluripotent stem cells, within days, to convert into skeletal myocytes, providing a high-quality, easy-to-use, cellular model.
Skeletal myocytes demonstrate robust expression of components of the contractile apparatus and form striated, multinucleated, myocytes by Day 10 post revival, that contract in response to acetylcholine.
Unprecedented batch-to-batch consistency allows for their use in demanding screening applications where small changes need to be detected against background noise.
Tackling the reproducibility crisis with standardized human cells
Tuesday, April 29, 2025 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Join experts in human iPSC-derived cells from academia and drug discovery as they discuss the impact of standardization on scientific progress.
The absence of standardized reagents creates barriers to reliable experimental comparisons, slowing research, drug development, and translational efforts. Across human cell models, including primary cells, cell lines, and patient-derived iPSC-derived cells, biological variability and reproducibility challenges persist.
In this expert panel, we will explore how standardizing human iPSC-derived cells can enhance consistency, reproducibility, and regulatory compliance, ultimately enabling more robust and impactful research.
Key learning objectives
- Explore the challenges posed by variability in human cell models
- Understand why a lack of standardized cell models impacts reproducibility, and how implementing it can improve research across academia and industry
- Gain insights on the standardization of human iPSC-derived cells from leaders in academic research and drug discovery
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
